---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-020143"
form_type: "8-K"
ticker: "COCP"
cik: "0001412486"
company_name: "Cocrystal Pharma, Inc."
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:17:23.144336+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cocrystal Pharma raises $1.03M in private placement with four insider investors at $1.39/unit

## Summary
- Sold 739,426 units (1 share + 2 warrants) at $1.39/unit for $1.03M to four accredited insider purchasers.
- Warrants exercisable at $1.24/share for 27 months; potential additional $1.83M if fully exercised.
- Insiders include Directors Phillip Frost, Fred Hassan, Richard Pfenniger, and co-CEO/CFO James Martin.
- Proceeds to support clinical antiviral development programs and general working capital.
- Offering exempt under Section 4(a)(2) and Regulation D; no registration rights granted.

## SEC filing metadata
- accession: 0001493152-25-020143
- form_type: 8-K
- ticker: COCP
- cik: 0001412486
- company_name: Cocrystal Pharma, Inc.
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412486/000149315225020143/0001493152-25-020143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412486/000149315225020143/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-020143
- JSON: https://secwatch.observer/filing/0001493152-25-020143.json
- Plain text: https://secwatch.observer/filing/0001493152-25-020143.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.